AXIM (AXIM Biotechnologies) Cyclically Adjusted FCF per Share: $-0.05 (As of Jun. 2025)


What is AXIM Biotechnologies Cyclically Adjusted FCF per Share?

AXIM Biotechnologies AXIM Cyclically Adjusted FCF per Share is $-0.05 as of Jun. 2025. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

AXIM Biotechnologies's adjusted free cash flow per share for the three months ended in Jun. 2025 was $-0.002. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.05 for the trailing ten years ended in Jun. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-06-28), AXIM Biotechnologies's current stock price is $0.0045. AXIM Biotechnologies's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2025 was $-0.05. AXIM Biotechnologies's Cyclically Adjusted Price-to-FCF of today is .


AXIM Biotechnologies  (OTCPK:AXIM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


AXIM Biotechnologies Cyclically Adjusted FCF per Share Related Terms


AXIM Biotechnologies Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Cyclically Adjusted FCF per Share Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.06 -0.05 0.00 0.00

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 0.00 0.00 -0.05

AXIM vs HEPA, SCNI, BZYR: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AXIM Biotechnologies Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Cyclically Adjusted Price-to-FCF falls into.



AXIM Biotechnologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AXIM Biotechnologies's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=-0.002/322.5610*322.5610
=-0.002

Current CPI (Jun. 2025) = 322.5610.

AXIM Biotechnologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.005 238.638 -0.007
201509 -0.012 237.945 -0.016
201512 -0.011 236.525 -0.015
201603 -0.005 238.132 -0.007
201606 -0.009 241.018 -0.012
201609 -0.005 241.428 -0.007
201612 -0.012 241.432 -0.016
201703 -0.011 243.801 -0.015
201706 -0.009 244.955 -0.012
201709 -0.019 246.819 -0.025
201712 -0.019 246.524 -0.025
201803 -0.021 249.554 -0.027
201806 -0.028 251.989 -0.036
201809 -0.018 252.439 -0.023
201812 -0.015 251.233 -0.019
201903 -0.012 254.202 -0.015
201906 -0.019 256.143 -0.024
201909 -0.028 256.759 -0.035
201912 -0.022 256.974 -0.028
202003 -0.014 258.115 -0.017
202006 -0.006 257.797 -0.008
202009 -0.007 260.280 -0.009
202012 -0.005 260.474 -0.006
202103 -0.005 264.877 -0.006
202106 -0.005 271.696 -0.006
202109 -0.004 274.310 -0.005
202112 -0.006 278.802 -0.007
202203 -0.005 287.504 -0.006
202206 -0.005 296.311 -0.005
202209 -0.002 296.808 -0.002
202212 -0.002 296.797 -0.002
202303 -0.001 301.836 -0.001
202306 -0.003 305.109 -0.003
202309 -0.001 307.789 -0.001
202312 0.000 306.746 0.000
202403 -0.004 312.332 -0.004
202406 0.002 314.175 0.002
202412 0.000 315.605 0.000
202503 0.000 319.799 0.000
202506 -0.002 322.561 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.05 mean?
AXIM Biotechnologies (AXIM) has a Cyclically Adjusted FCF per Share of $-0.05 as of Jun. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Cyclically Adjusted FCF per Share too high?
AXIM Biotechnologies' current Cyclically Adjusted FCF per Share is $-0.05.
How does AXIM Biotechnologies' Cyclically Adjusted FCF per Share compare to HEPA and SCNI?
AXIM Biotechnologies' Cyclically Adjusted FCF per Share of $-0.05 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Cyclically Adjusted FCF per Share is $-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Cyclically Adjusted FCF per Share of $-0.05. The current Cyclically Adjusted FCF per Share is $-0.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Cyclically Adjusted FCF per Share is $-0.05 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.